Cryo-Cell International, Inc. CCEL · Stock Open Cryo-Cell International, Inc. in new tab
Cryo-Cell International, Inc. Analysis (CCEL)
Is Cryo-Cell International, Inc. a good investment? Cryo-Cell International, Inc. (CCEL) is currently trading at 6.52 USD.
In terms of valuation, the stock trades at a P/E ratio of 130.40. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Cryo-Cell International, Inc. is expected to release its next earnings report on July 9, 2026. The market consensus estimate for Forward EPS is 0.08.
For income investors, Cryo-Cell International, Inc. pays a dividend yield of 15.34%. With a payout ratio of 500%, the dividend appears to be under pressure.
Investor FAQ
Does Cryo-Cell International, Inc. pay a dividend?
Yes, it pays an annual dividend of 1.00 USD (15.34% yield).
What asset class is Cryo-Cell International, Inc.?
Cryo-Cell International, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be July 9, 2026. The company currently has a trailing EPS of 0.05.
Company Profile
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
| Year | Total Dividends |
|---|---|
| ▸2025 |
0.40 USD
|
| May 30, 2025 | 0.1500 |
| Feb. 28, 2025 | 0.2500 |
| ▸2024 |
0.25 USD
|
| Nov. 29, 2024 | 0.2500 |
| ▸2022 |
0.90 USD
|
| Sept. 9, 2022 | 0.9000 |
Community Discussion